Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
albumin (Human) (Plasbumin) (1 trial)
hyperimmune caprine serum (2 trials)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Neoplasm Metastasis (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 2)
Trials (2 total)
Trial APIs (2 total)